Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Iron Deficiency and Iron Deficiency Anemia in Your Female Patients: Who Is at Risk, How to Diagnose, How to Manage

Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding

ReachMD Healthcare Image
Choose a format
Media formats available:
Take 1 Minute Challenge
1 Minute Challenge Completed
1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
  • Overview

    This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Malcolm G. Munro MD, FRCS(c), FACOG
    Clinical Professor, Department of Obstetrics & Gynecology
    David Geffen School of Medicine at UCLA
    Chair, Women’s Health Research Collaborative
    Los Angeles, CA

    Research: AbbVie, Pharmacosmos
    Ownership Interest: Channel Medical, Okon, Gynesonics, U-Vision 360
    Patent Holder: Simulators – Assigned to AAGL
    Consulting Fees: AbbVie, American Regent

    Michael Auerbach, MD
    Clinical Professor of Medicine
    Georgetown University School of Medicine
    Washington, DC

    Research: Covis Pharma

    Arjeme Denise Cavens, MD
    Instructor of Obstetrics and Gynecology
    Northwestern University Feinberg School of Medicine
    Chicago, IL

    No relevant relationships reported.

    Michael K. Georgieff, MD
    Martin Lenz Harrison Land Grant Chair in Pediatrics
    Professor of Pediatrics, Obstetrics and Gynecology, and Developmental Psychology
    University of Minnesota Medical School
    Minneapolis, MN

    No relevant relationships reported.

    Lee P. Shulman, MD, FACOG, FACMG
    The Anna Ross Lapham Professor and Chief
    Division of Clinical Genetics
    Feinberg School of Medicine of Northwestern University
    Chicago, IL

    Consulting Fees: Agile, Aspira, Bayer, Biogix, Celula China, Daiichi Sankyo, Mayne, Organon, Shield
    Other: Astellas (DSMB Chair)

    Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
    Owner and Family Nurse Practitioner
    Wright & Associates Family Healthcare
    Amherst, NH


    Consulting Fees: AbbVie, Biohaven, GSK, Idorsia, Merck, Moderna, Pfizer, Sanofi, Seqirus, Shield Therapeutics

    Reviewers/Content Planners/Authors:

    • Jennifer Brutsche, RN, BSN, AHA BLS Instructor, has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the basics of iron physiology, including its critical role in cellular processes, and impact on growth and development throughout the life span.
    • Identify appropriate screening and diagnosis methods throughout the life span.
    • Describe the potential impact of iron deficiency (ID)/ ID anemia (IDA) and its treatment, throughout the life span.
    • Identify the benefits and disadvantages of using oral iron therapies in the management of iron deficiency (ID) and ID anemia (IDA).


  • Target Audience

    This activity is designed to meet the educational needs of obstetrician-gynecologists, other women’s health HCPs, and primary care physicians.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 1.0 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until March 31, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Shield Therapeutics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule16 Apr 2024